Q2 2025 AVITA Medical Inc Earnings Call Transcript

Aug 7, 2025 / 08:30 PM GMT

Release Date Price: $5.38 (+0.37%)

Transcript 10-Q8-K

Key Points

Positve

Commercial revenue for the second quarter was $18.4 million, up 21% year over year.
The company secured a waiver for Q2 trailing 12-month revenue covenant and revised covenants for the next four quarters, providing financial flexibility.
Real-world analysis showed that Resell reduced hospital stay by 36% for burn patients, confirming its clinical and economic benefits.
The company introduced new products, Cohelix and Permiaderm, which contributed to revenue growth and expanded market reach.
AVITA Medical Inc (AVHHL) achieved a 36% improvement in net loss compared to the same period in 2024, indicating better financial management.

Negative

Sequential revenue was flat due to a temporary headwind related to reimbursement issues with Medicare and Medicaid Services.
The company lowered its 2025 financial forecast due to reimbursement disruptions impacting revenue.
Gross profit margin for the second quarter decreased to 81.2% from 86.1% in the same period in 2024, due to product mix and higher inventory reserves.
Cash and marketable securities decreased significantly from $35.9 million at the end of 2024 to $15.7 million as of June 30, 2025.
The company revised its full-year 2025 commercial revenue guidance downward, indicating slower than expected growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RCEL.OQ - AVITA Medical Inc
Q2 2025 AVITA Medical Inc Earnings Call
Aug 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Avita Medical 2nd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, we'll open up for questions. To ask a question during a session, you will need to press 101 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's call is being recorded. I want I hand it over to your first speaker today, Ben Atkins, Vice President in investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.